Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 256

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings

Open access
Lucien, Mentor Ali Ber, Canarie, Michael F., Kilgore, Paul E., Jean-Denis, Gladzdin, Fénélon, Natael, Pierre, Manise, Cerpa, Mauricio, Joseph, Gerard A., Maki, Gina, Zervos, Marcus J., Dely, Patrick, Boncy, Jacques, Sati, Hatim, Rio, Ana del, Ramon-Pardo, Pilar·2021·International Journal of Infectious Diseases

Abstract

The dissemination of COVID-19 around the globe has been followed by an increased consumption of antibiotics. This is related to the concern for bacterial superinfection in COVID-19 patients. The identification of bacterial pathogens is challenging in low and middle income countries (LMIC), as there are no readily-available and cost-effective clinical or biological markers that can effectively discriminate between bacterial and viral infections. Fortunately, faced with the threat of COVID-19 spread, there has been a growing awareness of the importance of antimicrobial stewardship programs, as well as infection prevention and control measures that could help reduce the microbial load and hence circulation of pathogens, with a reduction in dissemination of antimicrobial resistance. These measures should be improved particularly in developing countries. Studies need to be conducted to evaluate the worldwide evolution of antimicrobial resistance during the COVID-19 pandemic, because pathogens do not respect borders. This issue takes on even greater importance in developing countries, where data on resistance patterns are scarce, conditions for infectious pathogen transmission are optimal, and treatment resources are suboptimal.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijid.2020.12.087

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 256

Metadata

Authors
Lucien, M. A. B., Canarie, M. F., Kilgore, P. E., Jean-Denis, G., Fénélon, N., Pierre, M., Cerpa, M., Joseph, G. A., Maki, G., Zervos, M. J., Dely, P., Boncy, J., Sati, H., Rio, A. D., & Ramon-Pardo, P.
Venue
International Journal of Infectious Diseases
Publisher
Elsevier BV
Published
2021-03
Volume
104
Pages
250-254
ISSN
1201-9712 (ISSN-L)
OpenAlex
W3120081043
Cited by
256
References
43
FWCI
26.70
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings. https://app.cochat.ai/papers/10.1016/j.ijid.2020.12.087
The paper
Lucien, M. A. B., Canarie, M. F., Kilgore, P. E., Jean-Denis, G., Fénélon, N., Pierre, M., Cerpa, M., Joseph, G. A., Maki, G., Zervos, M. J., Dely, P., Boncy, J., Sati, H., Rio, A. D., & Ramon-Pardo, P. (2021). Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2020.12.087

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.